BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 22924250)

  • 21. Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.
    Ghosh S; Geahlen RL
    EBioMedicine; 2015 Nov; 2(11):1785-98. PubMed ID: 26870803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.
    Chakrabarti S; Sinha M; Thakurta IG; Banerjee P; Chattopadhyay M
    Curr Med Chem; 2013; 20(37):4648-64. PubMed ID: 23834172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.
    Ganguly G; Chakrabarti S; Chatterjee U; Saso L
    Drug Des Devel Ther; 2017; 11():797-810. PubMed ID: 28352155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress in Alzheimer's disease: implications for prevention and therapy.
    Behl C
    Subcell Biochem; 2005; 38():65-78. PubMed ID: 15709473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
    Dixit S; Fessel JP; Harrison FE
    Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress: apoptosis in neuronal injury.
    Loh KP; Huang SH; De Silva R; Tan BK; Zhu YZ
    Curr Alzheimer Res; 2006 Sep; 3(4):327-37. PubMed ID: 17017863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energy metabolism and inflammation in brain aging and Alzheimer's disease.
    Yin F; Sancheti H; Patil I; Cadenas E
    Free Radic Biol Med; 2016 Nov; 100():108-122. PubMed ID: 27154981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's pathogenesis and its link to the mitochondrion.
    Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
    Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus.
    Veselov IM; Vinogradova DV; Maltsev AV; Shevtsov PN; Spirkova EA; Bachurin SO; Shevtsova EF
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.
    Steffen J; Stenzel J; Ibrahim S; Pahnke J
    J Alzheimers Dis; 2018; 65(2):465-474. PubMed ID: 30040730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.
    Blass JP; Gibson GE
    Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.
    Chong ZZ; Li F; Maiese K
    Brain Res Brain Res Rev; 2005 Jul; 49(1):1-21. PubMed ID: 15960984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.
    Jiang T; Sun Q; Chen S
    Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-related differences in oxidative stress and neurodegeneration.
    Tenkorang MA; Snyder B; Cunningham RL
    Steroids; 2018 May; 133():21-27. PubMed ID: 29274405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.